ADMA Biologics (ADMA) SEC Filings & 10K Form

$6.55
+0.11 (+1.71%)
(As of 04/26/2024 ET)

Recent ADMA Biologics SEC Filings

DateFilerForm TypeView
04/15/2024
3:35 PM
ADMA Biologics (Filer)
Form DEFA14A
04/15/2024
3:40 PM
ADMA Biologics (Filer)
Form ARS
04/15/2024
3:31 PM
ADMA Biologics (Filer)
Form DEF 14A
04/02/2024
8:00 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
8:01 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
8:48 PM
ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
8:00 PM
ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:44 PM
ADMA Biologics (Subject)
Aisling Capital II LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
11:31 AM
ADMA Biologics (Subject)
TEACHERS ADVISORS, LLC (Filed by)
Form SC 13G/A
03/11/2024
11:24 AM
ADMA Biologics (Subject)
TIAA CREF INVESTMENT MANAGEMENT LLC (Filed by)
Form SC 13G/A
03/11/2024
11:19 AM
ADMA Biologics (Subject)
Nuveen Asset Management, LLC (Filed by)
Form SC 13G/A
03/08/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
8:01 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
8:00 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:00 PM
ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:00 PM
ADMA Biologics (Issuer)
Fong Bryant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:00 PM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:00 PM
ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:00 PM
ADMA Biologics (Issuer)
FINGER ALISON CECILY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
3:15 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
3:21 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
8:03 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
7:00 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
10:47 AM
ADMA Biologics (Subject)
TEACHERS ADVISORS, LLC (Filed by)
Form SC 13G
02/14/2024
10:50 AM
ADMA Biologics (Subject)
Nuveen Asset Management, LLC (Filed by)
Form SC 13G
02/14/2024
10:37 AM
ADMA Biologics (Subject)
TIAA CREF INVESTMENT MANAGEMENT LLC (Filed by)
Form SC 13G
01/08/2024
7:00 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
8:00 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
3:30 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
3:30 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2023
3:31 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
8:00 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
8:02 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
3:45 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
If you have $2,500 bucks… check this out (Ad)

This computer whiz has been averaging 234% per year with an undefeated strategy he calls… The “Income Glitch” And he’s been making out like a bandit with a 100% success rate on over 64 trade opportunities!

Click here to unlock the Income Glitch training workshop for free. 
10/02/2023
3:46 PM
ADMA Biologics (Issuer)
FINGER ALISON CECILY (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/24/2023
6:53 PM
ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2023
7:30 PM
ADMA Biologics (Issuer)
Fong Bryant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
4:09 PM
ADMA Biologics (Subject)
Fong Bryant (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2023
8:46 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2023
8:30 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2023
8:30 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
7:50 PM
ADMA Biologics (Subject)
LENZ BRIAN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
7:47 PM
ADMA Biologics (Subject)
Grossman Adam S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2023
6:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2023
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
8:00 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:30 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2023
6:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2023
6:31 AM
ADMA Biologics (Filer)
Form DEFA14A
05/02/2023
8:07 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ADMA) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners